Cargando…

The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase

INTRODUCTION: The diagnosis of antibody-mediated vascular rejection (AM-VR) should be reliable and accurate. We hypothesized that arterial C4d (C4d(art)) immunoperoxidase deposition represents endothelial interaction with antibody. METHODS: From 3309 consecutive, kidney transplant biopsies from a si...

Descripción completa

Detalles Bibliográficos
Autores principales: Nankivell, Brian J., Shingde, Meena, P’Ng, Chow H., Sharma, Ankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263238/
https://www.ncbi.nlm.nih.gov/pubmed/35812292
http://dx.doi.org/10.1016/j.ekir.2022.04.097
_version_ 1784742686392057856
author Nankivell, Brian J.
Shingde, Meena
P’Ng, Chow H.
Sharma, Ankit
author_facet Nankivell, Brian J.
Shingde, Meena
P’Ng, Chow H.
Sharma, Ankit
author_sort Nankivell, Brian J.
collection PubMed
description INTRODUCTION: The diagnosis of antibody-mediated vascular rejection (AM-VR) should be reliable and accurate. We hypothesized that arterial C4d (C4d(art)) immunoperoxidase deposition represents endothelial interaction with antibody. METHODS: From 3309 consecutive, kidney transplant biopsies from a single center, 100 vascular rejection (VR) cases were compared against rejection without arteritis (n = 540) and normal controls (n = 1108). The clinical utility of C4d(art) for diagnosis and classification of AM-VR was evaluated against an independent reference test. RESULTS: C4d(art) occurred in 20.4% of acute, 11.0% of subclinical, and 46% of VR episodes. Semiquantitative C4d(art) score significantly correlated with immunodominant donor-specific antibodies (DSAs) (rho = 0.500, P < 0.001), peritubular capillary C4d (C4d(ptc)), microvascular inflammation, and Banff v scores. Banff v3 arteritis suggested AM-VR. Addition of C4d(art) to Banff antibody-mediated rejection (AMR) schema increased diagnostic sensitivity for AM-VR from 57.9% to 93.0%, accuracy 74.0% to 92.0%, and specificity 95.4% to 90.2% versus Banff 2019 (using C4d(ptc)). Death-censored graft failure was associated with C4d(art) AM-VR criteria using Cox regression (adjusted hazard ratio [HR] 4.310, 95% CI 1.322–14.052, P = 0.015). VR was then etiologically classified into AM-VR (n = 57, including 36 mixed VR) or “pure” (TCM-VR, n = 43). AM-VR occurred within all post-transplant periods, characterized by greater total, interstitial, and microvascular inflammation, arterial and peritubular C4d, DSA levels, and graft failure rates compared with TCM-VR. Mixed VR kidneys had the greatest inflammatory burden and graft loss (P < 0.001). CONCLUSION: C4d(art) is a suggestive biomarker of the humoral alloresponse toward muscular arteries. Inclusion of C4d(art) into the Banff schema improved its diagnostic performance for detection of AM-VR and etiologic classification of arteritis.
format Online
Article
Text
id pubmed-9263238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92632382022-07-09 The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase Nankivell, Brian J. Shingde, Meena P’Ng, Chow H. Sharma, Ankit Kidney Int Rep Clinical Research INTRODUCTION: The diagnosis of antibody-mediated vascular rejection (AM-VR) should be reliable and accurate. We hypothesized that arterial C4d (C4d(art)) immunoperoxidase deposition represents endothelial interaction with antibody. METHODS: From 3309 consecutive, kidney transplant biopsies from a single center, 100 vascular rejection (VR) cases were compared against rejection without arteritis (n = 540) and normal controls (n = 1108). The clinical utility of C4d(art) for diagnosis and classification of AM-VR was evaluated against an independent reference test. RESULTS: C4d(art) occurred in 20.4% of acute, 11.0% of subclinical, and 46% of VR episodes. Semiquantitative C4d(art) score significantly correlated with immunodominant donor-specific antibodies (DSAs) (rho = 0.500, P < 0.001), peritubular capillary C4d (C4d(ptc)), microvascular inflammation, and Banff v scores. Banff v3 arteritis suggested AM-VR. Addition of C4d(art) to Banff antibody-mediated rejection (AMR) schema increased diagnostic sensitivity for AM-VR from 57.9% to 93.0%, accuracy 74.0% to 92.0%, and specificity 95.4% to 90.2% versus Banff 2019 (using C4d(ptc)). Death-censored graft failure was associated with C4d(art) AM-VR criteria using Cox regression (adjusted hazard ratio [HR] 4.310, 95% CI 1.322–14.052, P = 0.015). VR was then etiologically classified into AM-VR (n = 57, including 36 mixed VR) or “pure” (TCM-VR, n = 43). AM-VR occurred within all post-transplant periods, characterized by greater total, interstitial, and microvascular inflammation, arterial and peritubular C4d, DSA levels, and graft failure rates compared with TCM-VR. Mixed VR kidneys had the greatest inflammatory burden and graft loss (P < 0.001). CONCLUSION: C4d(art) is a suggestive biomarker of the humoral alloresponse toward muscular arteries. Inclusion of C4d(art) into the Banff schema improved its diagnostic performance for detection of AM-VR and etiologic classification of arteritis. Elsevier 2022-05-05 /pmc/articles/PMC9263238/ /pubmed/35812292 http://dx.doi.org/10.1016/j.ekir.2022.04.097 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Nankivell, Brian J.
Shingde, Meena
P’Ng, Chow H.
Sharma, Ankit
The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase
title The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase
title_full The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase
title_fullStr The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase
title_full_unstemmed The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase
title_short The Clinical and Pathologic Phenotype of Antibody-Mediated Vascular Rejection Diagnosed Using Arterial C4d Immunoperoxidase
title_sort clinical and pathologic phenotype of antibody-mediated vascular rejection diagnosed using arterial c4d immunoperoxidase
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263238/
https://www.ncbi.nlm.nih.gov/pubmed/35812292
http://dx.doi.org/10.1016/j.ekir.2022.04.097
work_keys_str_mv AT nankivellbrianj theclinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT shingdemeena theclinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT pngchowh theclinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT sharmaankit theclinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT nankivellbrianj clinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT shingdemeena clinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT pngchowh clinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase
AT sharmaankit clinicalandpathologicphenotypeofantibodymediatedvascularrejectiondiagnosedusingarterialc4dimmunoperoxidase